Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
第一作者:
B,Beuselinck
第一单位:
Department of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. benoit.beuselinck@uzleuven.be
作者:
医学主题词
血管生成抑制剂(Angiogenesis Inhibitors);癌, 肾细胞(Carcinoma, Renal Cell);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);肿瘤转移(Neoplasm Metastasis);多态性, 单核苷酸(Polymorphism, Single Nucleotide);吡咯类(Pyrroles);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1038/bjc.2012.548
PMID
23462807
发布时间
2022-03-16
- 浏览10
British journal of cancer
887-900页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



